{"id":"W2521453944","doi":"10.1182/blood.v120.21.3689.3689","title":"Long-Term Survival Analyses of an Ongoing Phase 2 Study of Brentuximab Vedotin in Patients with Relapsed or Refractory Hodgkin Lymphoma","year":2012,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Brentuximab vedotin; Medicine; Internal medicine; Oncology; CD30; Population; Refractory (planetary science); Phases of clinical research; Lymphoma; Surgery; Chemotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003595394,0.0006972821,0.001544373,0.00030281,0.0004029286,0.0008983399,0.0005841617,0.0008914903,0.00166935],"category_scores_gemma":[0.001859633,0.000342316,0.001206718,0.0003775038,0.0004887976,0.0007036196,0.0004552597,0.001919577,0.0004549894],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008735874,"about_ca_system_score_gemma":0.0009368249,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007437564,"about_ca_topic_score_gemma":0.001529196,"domain_scores_codex":[0.9989827,0.0005322668,0.00005832851,0.0001690274,0.0001264227,0.0001311243],"domain_scores_gemma":[0.9980496,0.0004028135,0.0004894586,0.0001775237,0.0002038861,0.0006767075],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.662268,0.03352945,0.156333,0.0009575824,0.005311294,0.0004715777,0.0006265041,0.002799067,0.03297955,0.0001864527,0.003524861,0.1010127],"study_design_scores_gemma":[0.172591,0.4899373,0.322216,0.00008695229,0.003483292,0.0005755225,0.0002337665,0.001825966,0.003843081,0.0002202115,0.004929536,0.00005748259],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.996161,0.001660721,0.0001733502,0.0001393408,0.00002855529,0.0005329637,0.0008535336,0.00001556357,0.0004351263],"genre_scores_gemma":[0.9935144,0.000814009,0.0005538646,0.0004345813,0.000087628,0.0008795361,0.003094088,0.000008192475,0.0006136179],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003595394,"threshold_uncertainty_score":0.01901448,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04077668588251582,"score_gpt":0.3398140904663099,"score_spread":0.2990374045837941,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}